Chemotherapy-induced Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Chemotherapy-induced Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults [Phase 1]
This Phase 1 trial assessed the safety and potential drug interaction between casopitant and ketoconazole in healthy adults and is now compl…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects [Phase 1]
This Phase 1 study evaluated potential pharmacokinetic interactions when oral casopitant is co-administered with oral dolasetron, granisetro…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Auricular Acupressure for Chemotherapy-Induced Nausea and Vomiting in Female Breast Cancer Patients [NA]
The clinical trial NCT02403037 evaluating auricular acupressure to prevent chemotherapy-induced nausea and vomiting in female breast cancer …
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED) [Phase 3]
This clinical trial update reports the completion of a Phase 3 study of MK0869 for the prevention of chemotherapy-induced nausea and vomitin…
-
CLINICAL_TRIALS trial_result · 2017-04-24Clinical Trial Update: Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy (0869-801)(COMPLETED) [Phase 4]
Phase 4 trial update showing completion of a study evaluating aprepitant to prevent chemotherapy-induced nausea and vomiting in patients rec…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Adolescents [Phase 2]
A Phase 2 trial assessing the relative bioavailability of an extemporaneous aprepitant suspension in adolescents for chemotherapy-induced na…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting [Phase 3]
A Phase 3 trial evaluated a quadruple antiemetic combination (aprepitant, olanzapine, palonosetron, and dexamethasone) for preventing chemot…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving Chemotherapy [Phase 2]
This Phase 2 pilot trial evaluated adding olanzapine and aprepitant to standard antiemetic therapy to prevent nausea and vomiting in pediatr…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients [Phase 2]
Phase 2 trial evaluating a combination of palonosetron, ondansetron, and dexamethasone for preventing delayed chemotherapy-induced nausea an…
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC [Phase 3]
Phase 3 multicenter trial evaluating APF530 (granisetron) given subcutaneously to prevent chemotherapy-induced nausea and vomiting in patien…
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Proof-of-Concept Trial of Palonosetron and Olanzapine Without Dexamethasone for the Prevention of CIN [NA]
A proof-of-concept clinical trial is testing palonosetron and olanzapine without dexamethasone to prevent chemotherapy-induced nausea and vo…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Effect of Iranian Traditional Medicine Remedy on Chemotherapy Induced Nausea and Vomiting [Phase 2]
The Phase 2 clinical trial evaluating an Iranian traditional medicine remedy for chemotherapy-induced nausea and vomiting has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors [Phase 2]
Phase 2 trial evaluating fosaprepitant plus a 5-HT3 receptor antagonist and dexamethasone for chemotherapy-induced nausea and vomiting in pa…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Acupuncture for Chemical Therapy Induced Nausea and Vomiting: a Cross-over Trail [NA]
The document notes the completion of a cross-over clinical trial evaluating acupuncture for chemotherapy-induced nausea and vomiting. No res…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Efficacy of Ginger as an Adjunctive Prophylaxis for Chemotherapy-induced Nausea and Vomiting [Phase 2]
Phase 2 clinical trial evaluating ginger as an adjunctive prophylaxis for chemotherapy-induced nausea and vomiting. The study is completed.
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Ph 3 Safety/Efficacy Study of Rolapitant for Prevention of CINV in Subjects Receiving Moderately Emetogenic Chemotherapy [Phase 3]
Phase 3 safety and efficacy study of rolapitant for prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately …
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy [Phase 3]
Phase 3 trial evaluating rolapitant for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemo…
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy [Phase 3]
Phase 3 trial evaluating rolapitant for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemo…
-
CLINICAL_TRIALS trial_result · 2015-10-15Clinical Trial Update: Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer [Phase 3]
A Phase 3 trial comparing antiemetic drugs to prevent delayed nausea after chemotherapy in adult cancer patients has completed. The document…
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Evaluation of the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens [NA]
A completed clinical trial evaluated whether ginger (Zingiber officinale) reduces nausea and vomiting in patients receiving cisplatin-based …
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031) [Phase 3]
Phase 3 trial evaluating fosaprepitant dimeglumine for prevention of chemotherapy-induced nausea and vomiting; results completed with posted…
-
CLINICAL_TRIALS trial_result · 2015-08-25Clinical Trial Update: An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects [Phase 1]
This Phase 1 open-label study assessed how a single IV dose of rolapitant affects the pharmacokinetics of digoxin, sulfasalazine, and the Co…
-
CLINICAL_TRIALS trial_result · 2015-08-25Clinical Trial Update: An Open-Label, Randomized, Pivotal, Bioequivalence Study of Oral and Intravenous Rolapitant [Phase 1]
This update reports the completion of a Phase 1 open-label, randomized bioequivalence study comparing oral and intravenous rolapitant for ch…
-
CLINICAL_TRIALS trial_result · 2015-08-25Clinical Trial Update: A Phase 1, 2-Part, Single Ascending Dose Assessment of the Safety, Tolerability, and Pharmacokinetics of Rolapitant Intravenous in Healthy Volunteers [Phase 1]
A Phase 1, two-part single ascending dose study evaluated the safety, tolerability, and pharmacokinetics of intravenous rolapitant in health…
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC) [Phase 4]
Phase 4 clinical trial evaluating aprepitant-based triple regimen for prevention of chemotherapy-induced nausea and vomiting in the first cy…